Aberforth Partners LLP, on behalf of discretionary clients, has disclosed its position in Crest Nicholson Holdings plc's relevant securities, representing 7.19% of the ordinary shares. The disclosure includes 18,484,444 shares and states that Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 3,670,594 shares included in the total disclosed above. This total includes 3,670,594 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

The disclosure also includes details of purchases made, with 75,622 ordinary shares purchased at a price of 248.2117p per unit. Additionally, the form outlines that there are no indemnity or other dealing arrangements, and no agreements, arrangements, or understandings relating to options or derivatives.

This Form 8.3 provides a comprehensive overview of Aberforth Partners LLP's position and dealings with Crest Nicholson Holdings plc's relevant securities, offering transparency and insight into their holdings and transactions.